Amgen stock trades steady as investors weigh recent revenue growth and obesity pipeline progress

Amgen stock trades steady as investors weigh recent revenue growth and obesity pipeline progress  Ad-hoc-news.de

Summary aggregated from Ad-hoc-news.de's public RSS feed. The full reporting belongs to Ad-hoc-news.de — please read it on their site.